J
Jonathan Kay
Researcher at University of Massachusetts Medical School
Publications - 232
Citations - 23189
Jonathan Kay is an academic researcher from University of Massachusetts Medical School. The author has contributed to research in topics: Rheumatoid arthritis & Nephrogenic systemic fibrosis. The author has an hindex of 50, co-authored 216 publications receiving 19743 citations. Previous affiliations of Jonathan Kay include American College of Rheumatology & Brigham and Women's Hospital.
Papers
More filters
Journal ArticleDOI
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.
Daniel Aletaha,Tuhina Neogi,Alan J. Silman,Julia Funovits,David T. Felson,Clifton O. Bingham,Neal S. Birnbaum,Gerd Burmester,Vivian P. Bykerk,Marc D. Cohen,Bernard Combe,Karen H. Costenbader,Maxime Dougados,Paul Emery,Gianfranco Ferraccioli,Johanna M. W. Hazes,Kathryn Hobbs,Tom W J Huizinga,Arthur Kavanaugh,Jonathan Kay,Tore K Kvien,Timothy J. Laing,Philip J. Mease,Henri A Ménard,Larry W. Moreland,Raymond L. Naden,Theodore Pincus,Josef S Smolen,Ewa Stanislawska-Biernat,Deborah P M Symmons,Paul P. Tak,Katherine S. Upchurch,Jiří Vencovský,Frederick Wolfe,Gillian A. Hawker +34 more
TL;DR: This new classification system redefines the current paradigm of RA by focusing on features at earlier stages of disease that are associated with persistent and/or erosive disease, rather than defining the disease by its late-stage features.
Journal ArticleDOI
2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.
Daniel Aletaha,Tuhina Neogi,Alan J. Silman,Julia Funovits,David T. Felson,Clifton O. Bingham,Neal S. Birnbaum,Gerd Burmester,Vivian P. Bykerk,Marc D. Cohen,Bernard Combe,Karen H. Costenbader,Maxime Dougados,Paul Emery,Gianfranco Ferraccioli,Johanna M. W. Hazes,Kathryn Hobbs,Tom W J Huizinga,Arthur Kavanaugh,Jonathan Kay,Tore K Kvien,Timothy J. Laing,Philip J. Mease,Henri A Ménard,Larry W. Moreland,Raymond L. Naden,Theodore Pincus,Josef S Smolen,Ewa Stanislawska-Biernat,Deborah P M Symmons,Paul P. Tak,Katherine S. Upchurch,Jiří Vencovský,Frederick Wolfe,Gillian A. Hawker +34 more
TL;DR: This new classification system redefines the current paradigm of RA by focusing on features at earlier stages of disease that are associated with persistent and/or erosive disease, rather than defining the disease by its late-stage features.
Journal ArticleDOI
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)
Maxime Dougados,Martin Soubrier,Anna Antunez,Peter V. Balint,Alejandro Balsa,Maya H Buch,Maya H Buch,Gustavo Casado,Jacqueline Detert,Bassel Elzorkany,Paul Emery,Paul Emery,Najia Hajjaj-Hassouni,Masayoshi Harigai,Shue Fen Luo,Reka Kurucz,Gabriel Maciel,Emilio Martin Mola,Carlomaurizio Montecucco,Iain B. McInnes,Helga Radner,Josef S Smolen,Yeong Wook Song,Harald E. Vonkeman,Kevin L. Winthrop,Jonathan Kay +25 more
TL;DR: In this multinational sample of rheumatoid arthritis patients, variability among countries was wide, not only in prevalence but also in compliance with recommendations for preventing and managing these comorbidities.
Journal ArticleDOI
Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial
Josef S Smolen,Jonathan Kay,Mittie K. Doyle,Robert Landewé,Eric L. Matteson,Jürgen Wollenhaupt,Norman Gaylis,Frederick T. Murphy,Jeffrey S Neal,Yiying Zhou,Sudha Visvanathan,Elizabeth C. Hsia,Mahboob Rahman +12 more
TL;DR: Golimumab reduced the signs and symptoms of rheumatoid arthritis in patients with active disease who had previously received one or more TNFalpha inhibitors.
Journal ArticleDOI
Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue
Colin Cooper,Colin Cooper,Rosalind A. Eeles,Rosalind A. Eeles,David C. Wedge,Peter Van Loo,Peter Van Loo,Peter Van Loo,Gunes Gundem,Ludmil B. Alexandrov,Barbara Kremeyer,Adam Butler,Andy G. Lynch,Niedzica Camacho,Charles E. Massie,Jonathan Kay,Hayley J. Luxton,S. Edwards,Zsofia Kote-Jarai,Nening Dennis,Sue Merson,Daniel Leongamornlert,Jorge Zamora,Cathy Corbishley,Sarah Thomas,Serena Nik-Zainal,Manasa Ramakrishna,Sarah O’Meara,Lucy Matthews,Jeremy Clark,Rachel Hurst,Richard Mithen,Robert G. Bristow,Robert G. Bristow,Paul C. Boutros,Paul C. Boutros,Michael Fraser,Michael Fraser,Susanna L. Cooke,Keiran Raine,David T. Jones,Andrew Menzies,Lucy Stebbings,Jon Hinton,Jon W. Teague,Stuart McLaren,Laura Mudie,Claire Hardy,Elizabeth Anderson,Olivia Joseph,Victoria Goody,Ben Robinson,Mark Maddison,Stephen J. Gamble,Christopher Greenman,Daniel M. Berney,Steven Hazell,Naomi Livni,Cyril Fisher,Chris Ogden,Pardeep Kumar,Alan Thompson,C. R. J. Woodhouse,David Nicol,Erik Mayer,Tim Dudderidge,Nimish Shah,Vincent Gnanapragasam,Thierry Voet,Peter J. Campbell,Andrew Futreal,Douglas F. Easton,Anne Y. Warren,Christopher S. Foster,Michael R. Stratton,Hayley C. Whitaker,Ultan McDermott,Daniel Brewer,Daniel Brewer,Daniel Brewer,David E. Neal +80 more
TL;DR: Genome-wide DNA sequencing was used to decrypt the phylogeny of multiple samples from distinct areas of cancer and morphologically normal tissue taken from the prostates of three men, demonstrating the existence of ongoing abnormal mutational processes, consistent with field effects, underlying carcinogenesis.